Emirate of Abu Dhabi Publication of Final Terms (8965L)
15 Septembre 2021 - 2:14PM
UK Regulatory
TIDMOUT7
RNS Number : 8965L
Emirate of Abu Dhabi
15 September 2021
Emirate of Abu Dhabi
Publication of Pricing Supplements
The following pricing supplements (the Pricing Supplements) are
available for viewing:
1. Pricing Supplement in relation to the issue of
U.S.$1,750,000,000 1.875 per cent. Notes due 2031 by the Emirate of
Abu Dhabi (the Issuer) under the Issuer's Global Medium Term Note
Programme (the Programme)
2. Pricing Supplement in relation to the issue of
U.S.$1,250,000,000 3.000 per cent. Notes due 2051 by the Issuer
under the Programme
Please read the disclaimer below "Disclaimer - Intended
Addressees" before attempting to access this service, as your right
to do so is conditional upon complying with the requirements set
out below.
To view the full document, please paste the following URL into
the address bar of your browser.
http://www.rns-pdf.londonstockexchange.com/rns/8965L_1-2021-9-15.pdf
http://www.rns-pdf.londonstockexchange.com/rns/8965L_2-2021-9-15.pdf
For further information, please contact:
Department of Finance
P.O. Box 246, Abu Dhabi
United Arab Emirates
Telephone: +971 2 810 1714
Fax: +971 2 622 9990
Email: DMO@dof.abudhabi.ae
DISCLAIMER - INTENDED ADDRESSEES
The Pricing Supplements referred to above must be read in
conjunction with the offering circular dated 28 May 2021 in respect
of the Programme, as supplemented by the supplement dated 8
September 2021 (the Offering Circular).
Please note that the information contained in the Pricing
Supplements and the Offering Circular may be addressed to and/or
targeted at persons who are residents of particular countries
(specified in the Pricing Supplements and/or the Offering Circular)
only and is not intended for use and should not be relied upon by
any person outside these countries and/or to whom the offer
contained in the Pricing Supplements and/or the Offering Circular
is not addressed. Prior to relying on the information contained in
the Pricing Supplements and/or the Offering Circular you must
ascertain from the Pricing Supplements and Offering Circular
whether or not you are part of the intended addressees of the
information contained therein.
The securities referred to in the Pricing Supplements have not
been and will not be registered under the United States Securities
Act of 1933, as amended (the Securities Act) or with any securities
regulatory authority of any state or other jurisdiction of the
United States, and may not be offered or sold within the United
States except pursuant to an exemption from, or in a transaction
not subject to, the registration requirements of the Securities
Act. Prospective purchasers are hereby notified that sellers of the
Notes may be relying on the exemption from the provisions of
Section 5 of the Securities Act provided by Rule 144A.
The Pricing Supplements has been made available to you in an
electronic form. You are reminded that documents transmitted via
this medium may be altered or changed during the process of
electronic transmission and consequently none of the Issuer, its
advisers nor any person who controls any of them nor any director,
officer, employee nor agent of it or affiliate of any such person
accepts any liability or responsibility whatsoever in respect of
any difference between the Final Terms made available to you in
electronic format and the hard copy version available to you on
request from the Issuer.
Your right to access this service is conditional upon complying
with the above requirement.
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms
and conditions, to analyse how you engage with the information
contained in this communication, and to share such analysis on an
anonymised basis with others as part of our commercial services.
For further information about how RNS and the London Stock Exchange
use the personal data you provide us, please see our Privacy
Policy.
END
PFTBDGDCDBBDGBU
(END) Dow Jones Newswires
September 15, 2021 08:14 ET (12:14 GMT)
Emirate Ab 25 S (LSE:OUT7)
Graphique Historique de l'Action
De Nov 2024 à Déc 2024
Emirate Ab 25 S (LSE:OUT7)
Graphique Historique de l'Action
De Déc 2023 à Déc 2024